Adrenomedullin haploinsufficiency predisposes to secondary lymphedema

Nikitenko, Leonid L.; Shimosawa, Tatsuo; Henderson, Stephen; Mäkinen, Taija; Shimosawa, Hiromi; Qureshi, Uzma; Pedley, R. Barbara; Rees, Margaret C.P.; Fujita, Toshiro; Boshoff, Chris

Abstract

Secondary lymphedema is a debilitating condition, and genetic factors predisposing to its development remain largely unknown. Adrenomedullin (AM) is peptide encoded, together with proadrenomedullin N-terminal peptide (PAMP), by the Adm gene (adrenomedullin gene). AM and its putative receptor calcitonin receptor-like receptor (CLR) are implicated in angiogenesis and lymphangiogenesis during embryogenesis and wound healing, suggesting their possible involvement in secondary lymphedema. To investigate whether AM deficiency predisposes to secondary lymphedema, we used heterozygous adult mice with Adm gene-knockin stop mutation, which selectively abrogated AM, but preserved PAMP, expression (Adm AM+/Δ animals). After hind limb skin incision, Adm messenger RNA expression was upregulated in wounded tissue of both Adm AM+/+ and Adm AM+/Δ mice. However, only Adm AM+/Δ animals developed limb swelling and histopathological lymphedematous changes, including epidermal thickening, elevated collagen fiber density, and increased microvessel diameter. Secondary lymphedema was prevented when circulating AM levels in Adm AM+/Δ mice were restored by systemic peptide delivery. In human skin, CLR was expressed in tissue components affected by lymphedema, including epidermis, lymphatics, and blood vessels. Our study identified a previously unrecognized role for endogenous AM as a key factor in secondary lymphedema pathogenesis and provided experimental in vivo evidence of an underlying germ-line genetic predisposition to developing this disorder. © 2013 The Society for Investigative Dermatology.

Citation

Nikitenko, L. L., Shimosawa, T., Henderson, S., Mäkinen, T., Shimosawa, H., Qureshi, U., Pedley, R. B., Rees, M. C., Fujita, T., & Boshoff, C. (2013). Adrenomedullin haploinsufficiency predisposes to secondary lymphedema. Journal of Investigative Dermatology, 133(7), 1768-1776. https://doi.org/10.1038/jid.2013.47

• Journal Article Type: Article
• Acceptance Date: Jan 9, 2013
• Online Publication Date: Jan 30, 2013
• Publication Date: Jul 1, 2013
• Deposit Date: May 2, 2022
• Publicly Available Date: Jun 20, 2022
• Journal: Journal of Investigative Dermatology
• Print ISSN: 0022-202x
• Publisher: Elsevier
• Peer Reviewed: Peer Reviewed
• Volume: 133
• Issue: 7
• Pages: 1768-1776
• DOI: https://doi.org/10.1038/jid.2013.47
• Public URL: https://hull-repository.worktribe.com/output/3570997